براءة اختراع الأدوية في ظل اتفاقية التريبس

Time cited in Arcif : 
7

Author

بوبترة، طارق

Source

مجلة العلوم الإنسانية

Issue

Vol. ب, Issue 48 (31 Dec. 2017), pp.149-157, 9 p.

Publisher

University of Mentouri

Publication Date

2017-12-31

Country of Publication

Algeria

No. of Pages

9

Main Subjects

Law

Abstract EN

In Light Of The Accession Of Manny Developing Countries To The WTO, The Latter Is Committed To The Agreements Emanating From Them, Foremost Among Them The Agreement On Trade-Related Aspects, Which Is One Of The Most Important Pillars Of The New International Order Because It Has Harmed Developing Countries Through The Monopoly Of Medicine.

In These Countries, As A Result, Countries Committed Themselves To Provide Pharmaceutical Protection To Pharmaceutical Products Derived From Developed Countries Exclusively, And Pledged To Preserve The Monopolistic Rights Of Patents And Thus Concluded The Convention On The Piracy Of Drugs To Developing Countries Which This Is Because The Majority Of Diseases Are Concentrated In Developing Countries And Algeria Is Not Immune To This Monopoly

American Psychological Association (APA)

بوبترة، طارق. 2017. براءة اختراع الأدوية في ظل اتفاقية التريبس. مجلة العلوم الإنسانية،مج. ب، ع. 48، ص ص. 149-157.
https://search.emarefa.net/detail/BIM-808053

Modern Language Association (MLA)

بوبترة، طارق. براءة اختراع الأدوية في ظل اتفاقية التريبس. مجلة العلوم الإنسانية مج. ب، ع. 48 (كانون الأول 2017)، ص ص. 149-157.
https://search.emarefa.net/detail/BIM-808053

American Medical Association (AMA)

بوبترة، طارق. براءة اختراع الأدوية في ظل اتفاقية التريبس. مجلة العلوم الإنسانية. 2017. مج. ب، ع. 48، ص ص. 149-157.
https://search.emarefa.net/detail/BIM-808053

Data Type

Journal Articles

Language

Arabic

Notes

يتضمن مراجع ببليوجرافية.

Record ID

BIM-808053